Delivery Order SPE2DB20D3103-SPE2DB25FP7Z4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drops (15 mL) with a ceiling value of $1,277.84 under a firm fixed-price contract structure. This is a non-set-aside award issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under the company's...
- This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is a $2,345.55 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of 0.5% Refresh Tears eye drops in 15ml bottles. The contract has a period of performance through June 14, 2024 and was awarded on June 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,227.39 firm-fixed-price delivery order is for the supply of 0.5% Refresh Tears eye drops in 15 ml bottles. The contract has an ultimate completion date of September 29, 2022 and was awarded on September 28, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
- The Defense Logistics Agency awarded a delivery order valued at $3,668.77 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial role as a pharmaceutical supplier to federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,360.12, is for the delivery of Refresh Tears 0.5% eye drops in 15 milliliter bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of February 24, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Refresh Tears 0.5% eye drops. The $1,254.10 firm fixed-price contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Refresh Tears 0.5% eye drops in 15 ml bottles, with a firm fixed price of $3,348.60 and a performance period ending on May 12, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Refresh Tears 0.5% eye drops in 15ml bottles to the Defense Logistics Agency (DLA). The $1,578.42 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,055.40 firm fixed-price delivery order is for the supply of "REFRESH TEARS 0.5% EYE DROP 15ML" and has a completion date of November 29, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds significant Indefinite Delivery Contracts...
- This federal contract award is for a one-year delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5% Refresh Tears eye drops in 15 ml bottles. The $1,033.98 firm-fixed-price contract does not have a set-aside designation, indicating open competition. This contract is a child order under a larger Indefinite Delivery Contract (IDC) vehicle valued at $999,999,999 held by AmerisourceBergen with the DLA...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7Z4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,033.20 to AmerisourceBergen Drug Corp for Refresh Tears 0.5% eye drop solution (15ml) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply needs across the military healthcare system. This delivery order falls under AmerisourceBergen's comprehensive $999.999 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad range of medications, vaccines, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract award demonstrates the company's established capability to fulfill federal procurement requirements for specialized pharmaceutical commodities on an expedited basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/8/25 |